Clinical Trial Update: Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating apatinib in combination with oral vinorelbine for metastatic HER2-negative breast cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN